ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2022

Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK.

Ioanna Vlachaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.